DigitalX to act as corporate advisor for two ICOs with massive global markets
Blockchain and cryptocurrency innovator, DigitalX (ASX:DCC), has been appointed corporate advisor for the initial coin offerings (ICOs) of Shivom and Bankorus — both finalists in the Global Blockchain Competition.
Bankorus, which is registered with FIRA and SEC, is the world’s first private wealth management platform for high net worth investors powered by artificial intelligence (AI) and built on the blockchain. The Bankorus team built the first robo-advisor in China, now servicing more than 200,000 high net worth clients (HNW – that is, clients with over US$30 billion in assets).
Shivom, on the other hand, aims to become the largest genomic data-hub platform in the world. Shivom token holders own their genomic data, control the right to access it, and receive rewards if they choose to share it.
DCC CEO, Leigh Travers, said: “Shivom’s medical genomic ecosystem will offer an open web-marketplace for contributors and health providers to add their apps and services, alongside genomic data analytics and personalized medicine.”
Travers continued: “DigitalX continues to strengthen its reputation for ICO advisory services and is now working with the world’s most promising blockchain companies as they raise capital to deliver their vision.”
The global cryptocurrency market is now worth $500 billion. It’s dwarfed by the high-net-worth market, which is estimated to be worth more than $60 trillion.
“Demand for high quality ICOs is growing in 2018 and DigitalX is pleased to be working with companies that already have an established global market for their technology,” said Travers.
Both Bankorus and Shivom are at a pre-ICO stage — DCC will provide technical expertise, marketing and promotion services, as well as introductions to its expansive global network. A prospectus for these companies will be made available when the securities are offered and those who wish to receive the prospectus or acquire the securities must complete the application form on the respective companies’ websites.
For its work with Bankorus, DCC will be paid in a mix of cryptocurrency (Bitcoin/Ether) and native (BKT) tokens in the project. The company will update the market on the outcome.
For services rendered to date, DCC has received US$500,000 in Ether and will receive US$1 million in native (OMX) tokens in the Shivom project.
DCC will roadshow both Bankorus and Shivom to its Australian network this week.
Due to strong demand, DCC has organised a conference in Perth, Sydney and Melbourne, in addition to one-on-one meetings with potential buyers and partners.
Last week, DCC reported record net profits of US$8 for the six months to 31 December, 2017, cementing its position as a pivotal global figure in the blockchain, crypto and ICO advisory space.
However, it’s worth noting that DCC is speculative at this stage and therefore investors should take all publicly available information into account and seek professional financial advice.
When the experts at Next Investors have a stock pick, it may pay to listen.
The Next Investors have been investing in ASX small cap stocks for years, with their best small cap picks yielding returns of 1,200%, 1,120%, 900% and 678%.
They have just revealed their hand-picked, FY2021 stock portfolio of high conviction long-term investments.
Click the link below to see what they are currently investing in.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.